Aescap Venture
PE/Buy-Out · Amsterdam (Netherlands)
Sign up free to access full profile and submit your pitch.
About
Aescap Venture is a principal investment firm specializing in investments in incubation, expansion, early stage, incubation, seed, early venture, mid venture, and late venture investments. It seeks to invest in life sciences ventures and medical companies that focus on the treatment of human diseases using genomics and proteomics, individualized treatment through gene expression profiling, next generation antibody therapeutics, stem-cell based therapies, and gene delivery techniques for vaccines and gene therapies technologies. Within life sciences, the firm invests in biotech, medical technology, and healthcare sectors and focus on public companies that develop market next-generation medical treatments. It typically invests in private companies based in Europe. The firm seeks to invests between €0.5 million ($0.71 million) and €5 million ($7.10 million) per transaction. It prefers to exit its investments between three years and seven years. The firm co-invests in subsequent rounds of funding. It also manages mutual fund that primarily invests in public equity of biotech sector. Aescap Venture was founded in 2006 and is based in Amsterdam, Netherlands.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.